Holen Sie sich die Stockscreener-App
32.18
1.73%
0.5407
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Is Collegium Pharmaceutical Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp - Defense World
What analysts say about Collegium Pharmaceutical Inc. stockLightning-fast capital gains - jammulinksnews.com
What drives Collegium Pharmaceutical Inc. stock priceBreakout portfolio performance - Autocar Professional
Collegium Pharmaceutical Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
Teacher Retirement System of Texas Decreases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical Inc. stock a good hedge against inflationBreakout Confirmation Tool - Newser
What risks could impact Collegium Pharmaceutical Inc. stock performanceFree Investment Community - Newser
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance
What makes Collegium Pharmaceutical Inc. stock price move sharplyMassive Gain Ideas - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityBalanced Risk Reward Portfolio - Newser
Why Collegium Pharmaceutical Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
(COLL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLC - Defense World
Collegium Pharmaceutical (COLL) Soars 1.98% on Strong Q1 Earnings - AInvest
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st
Collegium announces $150M share repurchase program - MSN
Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
Collegium Pharmaceutical authorizes $150 million share repurchase program By Investing.com - Investing.com Nigeria
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market - Nasdaq
Collegium Pharmaceutical authorizes $150 million share repurchase program - Investing.com
Collegium Announces $150 Million Share Repurchase Program - GlobeNewswire
COLL announces $150M share buyback through 2026 – cash-funded | COLL SEC FilingForm 8-K - Stock Titan
Collegium Expands Shareholder Returns With Fresh $150M Stock Buyback After Returning $222M Since 2021 - Stock Titan
Collegium Pharmaceutical Breaks Above 200-Day Moving AverageBullish for COLL - Nasdaq
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Buy” at Wall Street Zen - Defense World
How To Trade (COLL) - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Lowered by Illinois Municipal Retirement Fund - Defense World
Collegium Pharmaceutical Announces Share Repurchase Program Worth $25 Million - MSN
State of Alaska Department of Revenue Decreases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
SG Americas Securities LLC Has $426,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):